Fisher M, Balinth S, Hwangbo Y, Wu C, Ballon C, Goldberg G, et al. Cancer associated fibroblasts promote cancer stemness by inducing expression of the chromatin modifying protein CBX4 in squamous cell carcinoma. Carcinogenesis. 2023;: pubmed publisher

Sasamoto Y, Lee C, Wilson B, Buerger F, Martin G, Mishra A, et al. Limbal BCAM expression identifies a proliferative progenitor population capable of holoclone formation and corneal differentiation. Cell Rep. 2022;40:111166 pubmed publisher

Pinnamaneni J, Singh V, Kim M, Ryan C, Pugazenthi A, Sanagasetti D, et al. p63 silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiation. Sci Rep. 2022;12:11416 pubmed publisher

Van Sciver N, Ohashi M, Nawandar D, Pauly N, Lee D, Makielski K, et al. ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells. PLoS Pathog. 2021;17:e1010045 pubmed publisher

Fisher M, Balinth S, Hwangbo Y, Wu C, Ballon C, Wilkinson J, et al. BRD4 Regulates Transcription Factor ΔNp63α to Drive a Cancer Stem Cell Phenotype in Squamous Cell Carcinomas. Cancer Res. 2021;81:6246-6258 pubmed publisher

Westcott J, Camacho S, Nasir A, Huysman M, Rahhal R, Dang T, et al. ΔNp63 regulated epithelial-to-mesenchymal transition state heterogeneity confers a leader-follower relationship that drives collective invasion. Cancer Res. 2020;: pubmed publisher

Zheng J, Yun W, Park J, Kang P, Lee G, Song G, et al. Long-term expansion of directly reprogrammed keratinocyte-like cells and in vitro reconstitution of human skin. J Biomed Sci. 2020;27:56 pubmed publisher

Okada Y, Zhang Y, Zhang L, Yeh L, Wang Y, Saika S, et al. Shp2-mediated MAPK pathway regulates ΔNp63 in epithelium to promote corneal innervation and homeostasis. Lab Invest. 2019;: pubmed publisher

Somerville T, Xu Y, Miyabayashi K, Tiriac H, Cleary C, Maia Silva D, et al. TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma. Cell Rep. 2018;25:1741-1755.e7 pubmed publisher

Jiang Y, Jiang Y, Xie J, Mayakonda A, Hazawa M, Chen L, et al. Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression. Nat Commun. 2018;9:3619 pubmed publisher

Lin Shiao E, Lan Y, Coradin M, Anderson A, Donahue G, Simpson C, et al. KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis. Genes Dev. 2018;32:181-193 pubmed publisher

Porteiro B, Fondevila M, Delgado T, Iglesias C, Imbernon M, Iruzubieta P, et al. Hepatic p63 regulates steatosis via IKKβ/ER stress. Nat Commun. 2017;8:15111 pubmed publisher

Wang X, Boddicker R, Dasari S, Sidhu J, Kadin M, Macon W, et al. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping. Hum Pathol. 2017;64:19-27 pubmed publisher

Di Franco S, Turdo A, Benfante A, Colorito M, Gaggianesi M, Apuzzo T, et al. ?Np63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis. Oncotarget. 2016;7:54157-54173 pubmed publisher

Cam M, Gardner H, Roberts R, Fenger J, Guttridge D, London C, et al. ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma. Oncotarget. 2016;7:48533-48546 pubmed publisher

Yang K, Wu W, Chen Y, Lo S, Liao Y. ΔNp63α Transcriptionally Regulates the Expression of CTEN That Is Associated with Prostate Cell Adhesion. PLoS ONE. 2016;11:e0147542 pubmed publisher

Chatterjee A, Upadhyay S, Chang X, Nagpal J, Trink B, Sidransky D. U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of DeltaNp63alpha. Cell Cycle. 2008;7:1231-7 pubmed